Bio-Techne Corp (STU:TE1)
€ 69.5 0 (0%) Market Cap: 11.07 Bil Enterprise Value: 11.27 Bil PE Ratio: 80.74 PB Ratio: 5.63 GF Score: 95/100

Bio-Techne Corp at Robert W Baird Global Healthcare Conference Transcript

Sep 12, 2023 / 08:55PM GMT
Release Date Price: €67 (+1.52%)
Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Go ahead and get started. I'm Catherine Schulte, I cover life sciences and diagnostics here at Baird. Very excited to have Bio-Techne here with us today. From the company, we have CFO, Jim Hippel; and Head of IR, Dave Clair. So Dave, Jim, thanks so much for joining us.

James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO

Thanks for having us, and thanks for all of you. I can't believe it Clair. We got considered and we're bumping into a happy hour here. So I appreciate that.

Questions & Answers

Catherine Walden Ramsey Schulte
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

I think we're going to dive right into Q&A. If anyone from the audience has a question, you can send it to [email protected], and I will pass it along to the team. So maybe first starting off, coming off your Investor Day last week, maybe just give us a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot